Kazia Therapeutics (KZIA) Net Income (2009 - 2017)
Kazia Therapeutics (KZIA) posted Net Income of -$8.2 million for Q2 2017, up 9.97% on a QoQ basis from -$9.1 million in Q4 2016, and up 10.04% year-over-year from -$7.4 million in Q2 2016.
Kazia Therapeutics (KZIA) Net Income (2009 - 2017) Analysis & Trends
Kazia Therapeutics' Net Income history runs 9 years deep, the most recent figure standing at -$8.2 million for Q2 2017.
- Quarterly Net Income rose 10.04% year-over-year to -$8.2 million in Q2 2017, while the trailing twelve-month figure through Dec 2025 was $0.0 (changed 0.0% YoY) and the FY2025 annual result came in at -$13.3 million, up 24.13% from the prior year.
- Net Income was -$8.2 million for Q2 2017 at Kazia Therapeutics, up from -$9.1 million in the prior quarter.
- Across five years, Net Income topped out at -$1.4 million in Q4 2013 and bottomed at -$9.1 million in Q2 2016.
- A 5-year average of -$6.6 million and a median of -$7.3 million in 2014 frame the typical range for Net Income.
- Annual changes were most pronounced in 2014 — Net Income slumped 362.78% — and 2015, when it climbed 18.79%.
- Kazia Therapeutics' Net Income stood at -$1.4 million in 2013, then tumbled by 362.78% to -$6.5 million in 2014, then increased by 18.79% to -$5.3 million in 2015, then sank by 72.49% to -$9.1 million in 2016, then increased by 9.97% to -$8.2 million in 2017.
- Business Quant data shows KZIA's Net Income at -$8.2 million in Q2 2017, -$9.1 million in Q4 2016, and -$9.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -8.16 Mn |
| Dec 31, 2016 | -9.07 Mn |
| Jun 30, 2016 | -9.08 Mn |
| Dec 31, 2015 | -5.26 Mn |
| Dec 31, 2014 | -6.47 Mn |
| Dec 31, 2013 | -1.40 Mn |
| Dec 31, 2012 | -1.53 Mn |
| Oct 8, 2012 | -11.38 Mn |
| Dec 31, 2011 | 15.11 Mn |
| Dec 31, 2010 | -5.15 Mn |
| Dec 31, 2009 | -5.81 Mn |